» Articles » PMID: 19422538

Increased Frequency of Distinct TSC2 Allelic Variants in Focal Cortical Dysplasias with Balloon Cells and Mineralization

Overview
Journal Neuropathology
Specialties Neurology
Pathology
Date 2009 May 9
PMID 19422538
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Focal cortical dysplasias with balloon cells (FCD(IIb)) usually present with characteristic imaging and molecular features, that is, a transmantle sign on fluid-attenuated inversion recovery MRI and abundance of allelic variants of the tuberous sclerosis gene 1 (TSC1). Recently, we observed several mineralized lesions (n = 5) lacking this MRI pattern and which surprisingly turned out as FCD(IIb) upon neuropathological examination. These mineralized FCD(IIb) revealed an increased frequency of TSC2 allelic variants but not TSC1 (intron 31: 60% vs. 11% in controls; P = 0.0164, exon 41: 40% vs. 6.5% in controls; P = 0.0441). Mineralized FCD(IIb) have a favorable postsurgical outcome and need consideration in the presurgical differential diagnosis of calcified lesions associated with pharmacoresistant focal epilepsies.

Citing Articles

SCN1A overexpression, associated with a genomic region marked by a risk variant for a common epilepsy, raises seizure susceptibility.

Silvennoinen K, Gawel K, Tsortouktzidis D, Pitsch J, Alhusaini S, van Loo K Acta Neuropathol. 2022; 144(1):107-127.

PMID: 35551471 PMC: 9217876. DOI: 10.1007/s00401-022-02429-0.


Surgery for focal cortical dysplasia in children using intraoperative mapping.

Terra V, Thome U, Rosset S, Funayama S, Dos Santos A, Santos M Childs Nerv Syst. 2014; 30(11):1839-51.

PMID: 25296545 DOI: 10.1007/s00381-014-2459-7.


Incidental parenchymal magnetic resonance imaging findings in the brains of patients with neurofibromatosis type 2.

Vargas W, Heier L, Rodriguez F, Bergner A, Yohay K Neuroimage Clin. 2014; 4:258-65.

PMID: 24501699 PMC: 3913834. DOI: 10.1016/j.nicl.2013.12.010.


Mammalian target of rapamycin (mTOR) pathways in neurological diseases.

Wong M Biomed J. 2013; 36(2):40-50.

PMID: 23644232 PMC: 3880546. DOI: 10.4103/2319-4170.110365.


Finding a better drug for epilepsy: the mTOR pathway as an antiepileptogenic target.

Galanopoulou A, Gorter J, Cepeda C Epilepsia. 2012; 53(7):1119-30.

PMID: 22578218 PMC: 3389589. DOI: 10.1111/j.1528-1167.2012.03506.x.